IP Library Granted Patent US 8,048,138
Granted Patent B2
US 8,048,138 · App. 10/253,558 · Granted Nov 1, 2011

Medical device retaining sheath and medical device delivery system employing same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,048,138
App. No.
10/253,558
Granted
Nov 1, 2011
Kind
B2
Abstract

An endoluminal prosthetic delivery system provides a delivery sheath possessing a yield strength capable of allowing implantation of the prosthesis with increased efficiency. An endoluminal prosthesis is inserted in a body in a radially compressed condition, and expanded at an implantation site, whereby a delivery sheath or the prosthesis itself possesses a yield strength sufficient to allow radial expansion of the prosthesis. A method of implanting an endoluminal prosthesis is also herein provided.

Claims (46)

1. An endoluminal apparatus comprising:

a stent expandable from an unexpanded configuration to an expanded configuration; and

a sheath disposed around the stent, the sheath having a tubular structure comprising a first material at least partially embedded within a second material, the first material having a yield strength different from a yield strength of the second material such that when the stent expands from the unexpanded configuration to the expanded configuration, at least one of said first and second materials is plastically deformed.

2. The endoluminal apparatus of claim 1 wherein when the stent is expanded to the expanded configuration the sheath remains disposed around the stent.

3. The endoluminal apparatus of claim 1 wherein when the stent is expanded to the expanded configuration the sheath is removed from around the stent.

4. The endoluminal apparatus of claim 1 wherein after the stent is expanded to the expanded configuration the sheath is removed from around the stent.

5. The endoluminal apparatus of claim 1 wherein at least a portion of the sheath is at least partially bio-absorbable.

6. The endoluminal apparatus of claim 1 wherein at least a portion of the sheath is substantially cylindrical in shape.

7. The endoluminal apparatus of claim 1 wherein at least a portion of the sheath is formed by extrusion.

8. The endoluminal apparatus of claim 1 wherein said first material comprises a polymeric material.

9. The endoluminal apparatus of claim 8 wherein the second material comprises a polymeric material.

10. The endoluminal apparatus of claim 1 comprising a first portion and a second portion, the second portion comprising a wall thickness less than that of the first portion.

11. The endoluminal apparatus of claim 1 wherein when the stent expands from the unexpanded configuration to the expanded configuration, the first material deforms plastically and the second material deforms elastically.

12. The endoluminal apparatus of claim 1 wherein at least one of the first material and second material is selected from at least one member of the group consisting of: polyamide, polyurethane, polyimide, polytetrafluoroethylene, expanded polytetrafluoroethylene, polyether ether ketone, fluorinated ethylene propylene, polybutylene terephthalate and any combinations thereof.

13. The endoluminal apparatus of claim 1 wherein the yield strength of the first material is less than the yield strength of the second material.

14. The endoluminal apparatus of claim 1 comprising a plurality of first material portions, each first material portion at least partially embedded within said second material.

15. The endoluminal apparatus of claim 1 wherein the sheath defines at least one area having a tensile strength less than that of the rest of the sheath.

16. The endoluminal apparatus of claim 15 wherein the at least one area is defined by at least one notch or indentation in at least one surface of the sheath.

17. The endoluminal apparatus of claim 1 wherein the sheath defines a plurality of perforations, the plurality of perforations defining a break area, after the sheath is expanded from the first expansion state to the second expansion state the sheath will fracture along the break area.

18. The endoluminal apparatus of claim 1 wherein the sheath is at least one band, the at least one band having a first end and a second end, in the first expansion state the first end being engaged to the second end.

19. The endoluminal apparatus of claim 18 wherein in the second expansion state the first end remains engaged to the second end.

20. The endoluminal apparatus of claim 18 wherein in the second expansion state the first end and the second are not engaged one to the other.

21. A stent delivery system comprising:

a catheter including a balloon, the balloon comprising a pair of cones and a body portion therebetween, the body portion defining a medical device mounting region;

an expandable stent disposed about only the medical device mounting region of the catheter, the stent being expandable from an unexpanded configuration to an expanded configuration; and

a sheath comprising a first material at least partially embedded within a second material, the first material having a yield strength different from a yield strength of the second material, the sheath being disposed about the stent such that when the stent expands from the unexpanded configuration to the expanded configuration, at least one of said first and second materials is plastically deformed.

22. The stent delivery system of claim 21 wherein the stent comprises a self-expanding stent.

23. The stent delivery system of claim 21 wherein when the stent is expanded to the expanded configuration the sheath remains disposed about the stent.

24. The stent delivery system of claim 21 wherein when the stent is expanded to the expanded configuration the sheath is removed from about the stent.

25. The stent delivery system of claim 21 wherein after the stent is expanded to the expanded configuration the sheath is removed from about the stent.

26. The stent delivery system of claim 21 wherein at least a portion of the sheath is at least partially bio-absorbable.

27. The stent delivery system of claim 21 wherein at least a portion of the sheath is substantially tubular in shape.

28. The stent delivery system of claim 21 wherein at least a portion of the sheath is formed by extrusion.

29. The stent delivery system of claim 21 wherein at least one of said first and second materials comprises a polymeric material.

30. The stent delivery system of claim 21 wherein the yield strength of the first material is less than the yield strength of the second material.

31. The stent delivery system of claim 21 wherein the sheath comprises a first portion having a wall thickness less than that of a second portion.

32. The stent delivery system of claim 21 wherein the sheath comprises a plurality of first material portions, each first material portion at least partially embedded within said second material.

33. The stent delivery system of claim 21 wherein the first material is selected from at least one member of the group consisting of: polyamide, polyurethane, polyimide, polytetrafluoroethylene, expanded polytetrafluoroethylene, polyether ether ketone, fluorinated ethylene propylene, polybutylene terephthalate and any combinations thereof.

34. The stent delivery system of claim 21 wherein the yield strength of the second material is less than the yield strength of the first material.

35. The stent delivery system of claim 21 wherein the first material and the second material each comprise a polymeric material.

36. The stent delivery system of claim 21 wherein the sheath defines at least one area having a tensile strength less than that of the rest of the sheath.

37. The stent delivery system of claim 36 wherein the at least one area is defined by at least one notch or indentation in at least one surface of the sheath.

38. The stent delivery system of claim 21 wherein the sheath defines a plurality of perforations, the plurality of perforations defining a break area, after the sheath is expanded from the first expansion state to the second expansion state the sheath will fracture along the break area.

39. The stent delivery system of claim 21 wherein the sheath is at least one band, the at least one band having a first end and a second end, in the first expansion state the first end being engaged to the second end.

40. The stent delivery system of claim 39 wherein in the second expansion state the first end remains engaged to the second end.

41. The stent delivery system of claim 39 wherein in the second expansion state the first end and the second are not engaged one to the other.

Assignments (1)
CHANGE OF NAME Recorded Nov 6, 2006
From: SCIMED LIFE SYSTEMS, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 018505/0868 →